CA 125 for surgico-pathological stage 1 endometrial cancer

J Chin Med Assoc. 2024 May 1;87(5):453-454. doi: 10.1097/JCMA.0000000000001077. Epub 2024 Feb 21.

Authors

Peng-Hui Wang^{1

2

3}, Szu-Ting Yang^{1

2}

Affiliations

¹ Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
² Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
³ Female Cancer Foundation, Taipei, Taiwan, ROC.

PMID: 38380933
DOI: 10.1097/JCMA.0000000000001077

No abstract available

Publication types

Editorial

MeSH terms

CA-125 Antigen* / blood
Endometrial Neoplasms* / pathology
Female
Humans
Neoplasm Staging*

Substances

CA-125 Antigen